ロード中...
Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
Multimodal treatment is currently the standard of care for locally advanced esophagogastric junction (EGJ) adenocarcinoma due to poor results after surgery alone. Neoadjuvant therapy is intended to shrink the tumor and eliminate potential circulating tumor cells. However, which neoadjuvant treatment...
保存先:
| 出版年: | World J Clin Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8317651/ https://ncbi.nlm.nih.gov/pubmed/34367928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v12.i7.557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|